211 results
Page 8 of 11
8-K
EX-99.1
i7isbz9l6
25 Jun 20
Moleculin Announces Preclinical Data Confirms Efficacy of Annamycin in Lung Metastases
7:31am
8-K
EX-99.1
wm6j2vuh6tfpkr5
16 Jun 20
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
7:32am
8-K
EX-99.1
zpxeq12hyun6ht9u
28 May 20
Moleculin Announces Common Stock
7:30am
8-K
EX-99.1
ozwoplw4gd2r1 prruj
27 May 20
Moleculin Provides Update on Coronavirus Drug Development
5:20pm
8-K
EX-99.1
fg7831
18 May 20
Moleculin Announces Nasdaq Trading Halt Pending Receipt of Additional Information
4:01pm
8-K
EX-99.1
0huhdozib8p2wuj1ef88
11 May 20
Regulation FD Disclosure
7:31am
DEFA14A
0jku7 ch7mx386k
8 May 20
Additional proxy soliciting materials
7:31am
8-K
EX-99.1
ir06wj76txgmlniz09n
22 Apr 20
Moleculin Announces Head of NIAID Antiviral Drug Discovery and Development Center Joins COVID-19 Drug Development Team
7:30am
8-K
EX-99.1
vloafa9pvk pb
15 Apr 20
Moleculin Announces Leading Virologist Joins Development Team
7:30am
8-K
EX-99.1
ubaic0k 9y
14 Apr 20
Moleculin Announces Investor Conference Call to Discuss COVID-19 Potential for Drug Candidate
7:30am
8-K
EX-99.1
i7maiaixn
8 Apr 20
Other Events
7:30am
8-K
EX-99.1
1wvjd5 ddk
2 Apr 20
Moleculin Announces Additional Positive Safety Data in EU AML Trial
7:30am
8-K
EX-99.1
ez3 pagd6jvekwek6
19 Mar 20
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
3pt4abzmebgwcqm5dyf
17 Mar 20
Moleculin Signs Agreement with UTMB to Test WP1122 on a Range of Viruses, including Coronavirus
7:31am
8-K
EX-99.1
y2qtw
10 Mar 20
Moleculin Announces Dr. Hongbo Zhai Joins Science Advisory Board
7:31am
8-K
EX-99.1
abg uqll3gzc4hu
4 Mar 20
Moleculin Issues Video Shareholder Letter
7:31am
8-K
EX-99.1
ebxwwnno4e gnc
20 Feb 20
Moleculin Announces Positive Independent Report of No Cardiotoxicity in Annamycin Phase 1 To Date
7:32am
8-K
EX-99.1
qvg1 1t2g0e5q
18 Feb 20
Moleculin Presents Clinical Trial Data Demonstrating a Median Reduction of 56% in Skin Cancer Lesions
7:30am